Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Origin Capital Management is a San Francisco-based investment management firm and family office specializing in the healthcare, biotechnology, and life sciences sectors. Founded in 2000 by Buzz Burlock, a former Managing Director at Soros Fund Management, the firm manages public and private equity investments with a focus on fundamental research and clinical-stage asset evaluation. Origin is well-regarded for its deep sector expertise, and its alumni have gone on to hold executive positions at major biopharmaceutical companies such as Genentech and Reata Pharmaceuticals. The firm's investment portfolio has included notable healthcare and health-tech companies, such as the mental health platform Lyra Health and the managed care organization Centene Corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Origin Capital Management.